Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo

Cancer Letters

Volumn 323, Issue 1, 2012, Pages 58-61

  Yildirim, Senay ^a,b   Altun, Seyhan ^a   Gumushan, Hatice ^a,c   Patel, Anup ^b   Djamgoz, Mustafa B A ^b,d  

^a ISTANBUL UNIVERSITY   (Turkey)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c HARRAN UNIVERSITY   (Turkey)

^d CYPRUS INTERNATIONAL UNIVERSITY   (Turkey)

Author keywords

Dunning cell; Mat LyLu; Metastasis; Prostate cancer; Tetrodotoxin; Voltage gated sodium channel

Indexed keywords

TETRODOTOXIN; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CONTROLLED STUDY; COPENHAGEN RAT; IN VIVO STUDY; LUNG METASTASIS; MALE; MOLECULAR PATHOLOGY; NONHUMAN; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SURVIVAL RATE; SURVIVAL TIME; TUMOR PROMOTION; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; MALE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RATS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TETRODOTOXIN;

RATTUS;

EID: 84861802166     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.03.036     Document Type: Article

References (28)

1. Fiske J.L., Fomin V.P., Brown M.L., Duncan R.L., Sikes R.A. Voltage-sensitive ion channels and cancer. Cancer Metast. Rev. 2006, 25:493-500.
2. Onkal R., Djamgoz M.B.A. Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer. Eur. J. Pharmacol. 2009, 625:206-219.
3. + channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion. Cancer Res. 2010, 70:6957-6967.
4. Fraser S.P., Diss J.K.J., Chioni A.M., Mycielska M.E., Pan H., Yamaci R.F., Pani F., Siwy Z., Krasowska M., Grzywna Z., Brackenbury W.J., Theodorou D., Koyutürk M., Kaya H., Battaloglu E., De Bella M.T., Slade M.J., Tolhurst R., Palmieri C., Jiang J., Latchman D.S., Coombes R.C., Djamgoz M.B.A. Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clin. Cancer Res. 2005, 11:5381-5389.
5. + channel expression. Eur. Biophys. J. 2008, 37:359-368.
6. + channels in human prostate cancer cell lines and their contribution to invasion in vitro. Am. J. Pathol. 1997, 150:1213-1221.
7. Nakajima T., Kubota N., Tsutsumi T., Oguri A., Imuta H., Jo T., Oonuma H., Soma M., Meguro K., Takano H., Nagase T., Nagata T. Eicosapentaenoic acid inhibits voltage-gated sodium channels and invasiveness in prostate cancer cells. Br. J. Pharmacol. 2009, 156:420-431.
8. Brackenbury W.J., Chioni A.M., Diss J.K.J., Djamgoz M.B.A. The neonatal splice variant of Nav1.5 potentiates in vitro invasive behaviour of MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 2007, 101:149-160.
9. Diss J.K.J., Stewart D., Pani F., Foster C.S., Walker M.M., Patel A., Djamgoz M.B.A. A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis. 2005, 8:266-273.
10. + channel alpha-subunit genes in rat and human prostate cancer cell lines. Prostate 2001, 48:165-178.
11. + currents in two prostatic tumour cell lines: contribution to invasiveness in vitro. FEBS Lett. 1995, 369:290-294.
12. + current expressed in the highly metastatic Mat-LyLu cell line of rat prostate cancer. J. Cell. Physiol. 1998, 175:50-58.
13. + channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility. J. Cell. Physiol. 2003, 195:479-487.
14. + channel expression in Mat-LyLu rat prostate cancer cell line. J. Physiol. 2006, 573:343-356.
15. Dunning W.F. Prostate cancer in the rat. Natl. Cancer Inst. Monogr. 1963, 12:351-369.
16. Isaacs J.T., Isaacs W.B., Feitz W.F., Scheres J. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 1986, 9:261-281.
17. Rodriguez-Navarro A.J., Lagos N., Lagos M., Braghetto I., Csendes A., Hamilton J., Figueroa C., Truan D., Garcia C., Rojas A., Iglesias V., Brunet L., Alvarez F. Neosaxitoxin as a local anaesthetic: preliminary observations from a first human trial. Anesthesiology 2007, 106:339-345.
18. Fraser S.P., Grimes J.A., Djamgoz M.B.A. Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: comparison of strongly and weakly metastatic cell lines. Prostate 2000, 44:61-76.
19. Stafford L.J., Vaidya K.S., Welch D.R. Metastasis suppressor genes in cancer. Int. J. Biochem. Cell Biol. 2008, 40:874-891.
20. Garrow G.C., Greco F.A., Hainsworth J.D. Poorly differentiated neuroendocrine carcinoma of unknown primary tumor site. Semin. Oncol. 1993, 20:287-291.
21. Boehnke S.E., Rasmusson D.D. Time course and effective spread of lidocaine and tetrodotoxin delivered via microdialysis: an electrophysiological study in cerebral cortex. J. Neurosci. Meth. 2001, 105:133-141.
22. Galati S., Stanzione P., D'Angelo V., Fedele E., Marzetti F., Sancesario G., Procopio T., Stefani A. The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. J. Physiol. 2009, 587:4405-4423.
23. Ilie C.P., Chancellor M.B. Perspective of Botox for treatment of male lower urinary tract symptoms. Curr. Opin. Urol. 2009, 19:20-25.
24. Mamelak A.N., Rosenfeld S., Bucholz R., Raubitschek A., Nabors L.B., Fiveash J.B., Shen S., Khazaeli M.B., Colcher D., Liu A., Osman M., Guthrie B., Schade-Bijur S., Hablitz D.M., Alvarez V.L., Gonda MA M.A. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J. Clin. Oncol. 2006, 24:3644-3650.
25. Clare J.J., Tate S.N., Nobbs M., Romanos M.A. Voltage-gated sodium channels as therapeutic targets. Drug Discov. Today 2000, 5:506-520.
26. Gillet L., Roger S., Besson P., Lecaille F., Gore J., Bougnoux P., Lalmanach G., Le Guennec J.-Y. Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells. J. Biol. Chem. 2009, 284:8680-8691.
27. + efflux in caveolae. Oncogene 2011, 30:2070-2076.
28. Nomura T., Katunuma N. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J. Med. Invest. 2005, 52:1-9.